Meeting Report
Best Practices in the Management of Infectious Complications for Patients With Cancer: Management of Febrile Neutropenia
Presented by Kyle C. Molina, PharmD, BCIDP, AAVHIP
From University of Colorado Hospital, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, and University of Colorado School of Medicine, Aurora, Colorado
Presenter’s disclosure of conflict of interest is found at the end of this article.
J Adv Pract Oncol 2023;14(3):201–206 |
https://doi.org/10.6004/jadpro.2023.14.3.4 |
© 2023 Harborside™
ABSTRACT
Managing infection in patients with neutropenia is a difficult challenge, as fever is often the only clinical symptom. At JADPRO Live 2022, Kyle C. Molina, PharmD, BCIDP, AAVHIP, of the University of Colorado Hospital, discussed the epidemiology and pathophysiology associated with febrile neutropenia in patients with cancer. He reviewed appropriate treatment settings and empiric antimicrobial regimens for a patient and how to formulate a plan to safely de-escalate and target therapy for patients with febrile neutropenia.
For access to the full length article, please
sign in.
